This topic contains a solution. Click here to go to the answer

Author Question: Sexual fidelity, according to evolutionary theory, A) is greater in females than in males. B) is ... (Read 306 times)

ec501234

  • Hero Member
  • *****
  • Posts: 573
Sexual fidelity, according to evolutionary theory,
 
  A) is greater in females than in males.
  B) is greater in males than in females.
  C) is equal in both sexes.
  D) is explained by cultural norms, not natural selection.

Question 2

The sexes differ in attitudes toward sexual promiscuity, according to evolutionary theory, because of
 
  A) differences in parental investment.
  B) different social norms.
  C) parental uncertainty.
  D) differences in the age of puberty.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

johnharpe

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

Answer: A

Answer to Question 2

Answer: A




ec501234

  • Member
  • Posts: 573
Reply 2 on: Jun 21, 2018
Thanks for the timely response, appreciate it


strudel15

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library